|
8:00 |
8:30 |
9:00 |
9:30 |
10:00 |
10:30 |
11:00 |
11:30 |
12:00 |
12:30 |
13:00 |
13:30 |
14:00 |
14:30 |
15:00 |
15:30 |
16:00 |
16:30 |
17:00 |
17:30 |
18:00 |
Mon |
|
|
BIOC3231/32/BIOL3211 LEC 04/01 JA <29> |
Bayliss,Richard,Prof |
Roger Stevens LT 19 (10.19) |
Synthetic Biology |
18 |
|
|
|
|
|
BIOC3231/32/BIOL3211/MICR3212 LEC 12/01 JA <28> |
Randall,Chris,Dr |
Roger Stevens LT 20 (7M.20) |
Human-microbe interactions |
17 |
|
|
|
BIOC3231/32/BIOL3211 LEC 06/01 JA <30> |
Berry,Alan,Prof |
Roger Stevens LT 17 (7.17) |
Synthetic Biology |
19 |
|
BIOC3231/32/BIOL3211/MICR3212 LEC 10/01 JA <28> |
Herod,Morgan,Dr |
Roger Stevens LT 25 (12.25) |
Human-microbe interactions |
17 |
|
|
|
|
|
|
BIOC3231/32/BIOL3211 LEC 04/01 JA <30> |
Berry,Alan,Prof |
Roger Stevens LT 19 (10.19) |
Synthetic Biology |
19 |
|
|
|
|
|
BIOC3231/32/BIOL3211/MICR3212 LEC 12/01 JA <27> |
McDowall,Kenneth,Prof |
Roger Stevens LT 20 (7M.20) |
Human-microbe interactions |
16 |
|
|
|
BIOC3231/32/BIOL3211 LEC 06/01 JA <29> |
Berry,Alan,Prof |
Roger Stevens LT 17 (7.17) |
Synthetic Biology |
18 |
|
BIOC3231/32/BIOL3211/MICR3212 LEC 10/01 JA <27> |
McDowall,Kenneth,Prof |
Roger Stevens LT 25 (12.25) |
Human-microbe interactions |
16 |
|
|
|
|
|
|
BIOC3231/32/BIOL3211/MICR3212 LEC 04/01 JA |
Seipke,Ryan,Dr |
Roger Stevens LT 25 (12.25) |
Streptomyces, the Antibiotic Makers |
14-15 |
|
|
|
|
|
BIOC3231/32/BIOL3211 LEC 05/01 JA <30> |
Berry,Alan,Prof |
Roger Stevens LT 22 (10M.22) |
Synthetic Biology |
19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BIOC3231/32/BIOL3211 LEC 01/01 JA <27> |
Odell,Adam,Dr, Ponnambalam,Sreenivasan,Dr |
Roger Stevens LT 22 (10M.22) |
Guest speaker: Dr Adam Odell |
16 |
|
|
|
|
|
BIOC3231/32/BIOL3211 LEC 05/01 JA <29> |
Bayliss,Richard,Prof |
Roger Stevens LT 22 (10M.22) |
Synthetic Biology |
18 |
|
|
|
|
|
BIOL3215/11/BIOC3231/32/MICR3212 LEC 05/01 JA |
Laslo,Peter,Dr |
Chemical and Process Engineering LT A (2.23) |
Haematological cancers: Chronic Myeloid Leukaemia |
18 |
|
|
|
|
|
|
|
|
BIOC3231/32/BIOL3211 LEC 01/01 JA <28> |
Riobo-Del Galdo,Natalia,Dr |
Roger Stevens LT 22 (10M.22) |
Signal transduction in cancer and cardiovascular disease |
17 |
|
|
|
|
|
|
|
|
|
|
|
BIOC3231/32/BIOL3211/MICR3212 LEC 02/01 JA |
Westhead,David,Prof |
Roger Stevens LT 25 (12.25) |
Haematological cancers |
20 |
|
|
|
|
|
|
Tue |
|
|
|
|
|
|
|
|
|
|
BIOL3215/11/BIOC3231/32/MICR3212/BMSC3233/34/35/36 LEC 01/01 JA <26> |
Blair,Eric,Prof |
Conference Auditorium 2 (GM.01) |
Molecular oncology |
15 |
|
|
|
BIOL3215/11/BIOC3231/32/MICR3212 LEC 06/01 JA |
Laslo,Peter,Dr |
Roger Stevens LT 20 (7M.20) |
Haematological cancers: Chronic Myeloid Leukaemia |
18 |
|
|
|
|
|
|
Wed |
|
|
BIOL3215/11/BIOC3231/32/MICR3212/BMSC3233/34/35/36 LEC 02/01 JA <26> |
Blair,Eric,Prof |
Roger Stevens LT 21 (8M.21) |
Molecular oncology |
15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BIOL3215/11/BIOC3231/32/MICR3212/BMSC3233/34/35/36 LEC 02/01 JA <25> |
Whitehouse,Adrian,Prof |
Roger Stevens LT 21 (8M.21) |
Molecular oncology |
14 |
|
|
|
|
|
|
|
BIOC3231/32/BIOL3211/MICR3212 LEC 03/01 JA |
Westhead,David,Prof |
Conference Auditorium 2 (GM.01) |
Haematological cancers |
20 |
|
|
|
|
|
|
|
|
|
|
Thu |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BIOC3231/32/BIOL3211 LEC 02/01 JA <27> |
Riobo-Del Galdo,Natalia,Dr |
Roger Stevens LT 20 (7M.20) |
Signal transduction in cancer and cardiovascular disease |
16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BIOC3231/32/BIOL3211 LEC 02/01 JA <28> |
Odell,Adam,Dr |
Roger Stevens LT 20 (7M.20) |
Signal transduction in cancer and cardiovascular disease |
17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BIOC3231/32/BIOL3211/MICR3212 LEC 08/01 JA <31> |
Doody,Gina,Dr |
Roger Stevens LT 20 (7M.20) |
Stem cells |
20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BIOC3221/22/31/32/BIOL3210/11/MICR3211/1201/WKS 01 JA |
Edwards,Thomas,Dr |
Michael Sadler RBLT (LG.X04) |
Essay writing |
23 |
|
BIOL3215/11/BIOC3231/32/MICR3212 LEC 04/01 JA |
Laslo,Peter,Dr |
Roger Stevens LT 20 (7M.20) |
Haematological cancers: Chronic Myeloid Leukaemia |
18 |
|
|
|
|
|
|
|
|
|
|
BIOC3231/32/BIOL3211/MICR3212/LEC 20/01 JA <27> |
McDowall,Kenneth,Prof |
Roger Stevens LT 25 (12.25) |
Human-microbe interactions |
16 |
|
|
|
|
|
|
|
BIOC3231/32/BIOL3211/MICR3212/LEC 20/01 JA <28> |
Randall,Chris,Dr |
Roger Stevens LT 19 (10.19) |
Human-microbe interactions |
17 |
|
BIOC3231/32/BIOL3211/MICR3212 LEC 08/01 JA <32> |
Laslo,Peter,Dr |
Roger Stevens LT 20 (7M.20) |
Stem cells |
21 |
|
|
|
|
|
|
Fri |
|
|
BIOC3231/32/BIOL3211/MICR3212 LEC 06/01 JA <26> |
Seipke,Ryan,Dr |
Roger Stevens LT 25 (12.25) |
Streptomyces, the Antibiotic Makers |
15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BIOC3231/32/BIOL3211 LEC 03/01 JA <28> |
Ponnambalam,Sreenivasan,Dr |
Roger Stevens LT 17 (7.17) |
Signal transduction in cancer and cardiovascular disease |
17 |
|
|
|
BIOC3231/32/BIOL3211/MICR3212 LEC 06/01 JA <25> |
Seipke,Ryan,Dr |
Roger Stevens LT 22 (10M.22) |
Streptomyces, the Antibiotic Makers |
14 |
|
|
|
|
|
|
|
BIOC3231/32/BIOL3211/MICR3212 LEC 07/01 JA <31> |
Doody,Gina,Dr |
Roger Stevens LT 25 (12.25) |
|
20 |
|
|
|
BIOL3215/11/BIOC3231/32/MICR3212/BMSC3233/34/35/36 LEC 03/01 JA <26> |
Whitehouse,Adrian,Prof |
Roger Stevens LT 21 (8M.21) |
Molecular oncology |
15 |
|
|
|
|
BIOC3231/32/BIOL3211 LEC 03/01 JA <27> |
Riobo-Del Galdo,Natalia,Dr |
Roger Stevens LT 17 (7.17) |
Signal transduction in cancer and cardiovascular disease |
16 |
|
|
|
|
|
|
|
|
|
|
|
BIOC3231/32/BIOL3211/MICR3212 LEC 07/01 JA <32> |
Doody,Gina,Dr |
Roger Stevens LT 25 (12.25) |
Stem cells |
21 |
|
|
|
|
|
|
|
|
BIOL3215/11/BIOC3231/32/MICR3212/BMSC3233/34/35/36 LEC 01/01 JA <25> |
Whitehouse,Adrian,Prof |
Conference Auditorium 2 (GM.01) |
Molecular oncology |
14 |
|
BIOC3231/32/BIOL3211/MICR3212 LEC 09/01 JA |
Laslo,Peter,Dr |
Michael Sadler RBLT (LG.X04) |
Stem cells |
20-21 |
|
|
|
|
|
|
|
|
|
BIOC3231/32/BIOL3211/MICR3212 LEC 05/01 JA |
Seipke,Ryan,Dr |
Roger Stevens LT 25 (12.25) |
Streptomyces, the Antibiotic Makers |
14-15 |
|
|
|
BIOC3231/32/BIOL3211/MICR3212 LEC 01/01 JA |
Westhead,David,Prof |
Roger Stevens LT 25 (12.25) |
Haematological cancers |
20 |
|
|
Sat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sun |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|